<DOC>
	<DOCNO>NCT02508155</DOCNO>
	<brief_summary>The purpose study assess safety , drug level effect body MEDI7352 , subject painful osteoarthritis knee .</brief_summary>
	<brief_title>A Study MEDI7352 Painful Osteoarthritis Knee</brief_title>
	<detailed_description>An interleaved SAD/MAD Study ass safety , tolerability , pharmacokinetics pharmacodynamics MEDI7352 subject painful osteoarthritis knee .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Male female subject painful osteoarthritis ( OA ) knee . Female subject must postmenopausal surgically sterile . Body weight 50kg 145kg Willing able comply requirement protocol Current treatment another biologic therapeutic agent Current historical diagnosis RA Current diagnosis immunological condition associate another form arthritis addition OA , include traumatic arthritis seronegative spondyloarthropathy At risk destructive arthropathy , include Rapidly Progressive Osteoarthritis ( RPOA ) , osteonecrosis , spontaneous osteonecrosis knee , subchondral insufficiency fracture , hip dislocation pathological fracture Presence clinically significant neuropathy clinically significant disorder involve abnormal peripheral sensation . Current serious unstable clinically important illness .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>